Pure erythroid leukaemias

Dr Montalbán Bravo meets with ecancertv at ASH 2016 to discuss the aetiology and prognostic outlook of pure erythroid leukaemia, a subset of acute leukaemia.

He discusses the cell lineage of the disease, and describes sequencing data helping to form a greater genetic and biological understanding of PEL and its treatment choices.

Dr Montalbán Bravo also spoke with ecancer about the clinical utility of guadecitabine and azacitadine plus verinostat.